Skip to content

Dexcom G6 CGM

DEVICE10 trials

Sponsors

Oregon Health and Science University, Imperial College London, Sansum Diabetes Research Institute, Universitaire Ziekenhuizen KU Leuven, Blanchard Valley Health System

Conditions

CGMDiabetes Mellitus, Type 1Diabetic KetoacidosisDysglycemiaExerciseHypoglycemiaHypoglycemia UnawarenessMDI

Unknown Phase

Evaluation of Physician-based Decision Support
CompletedNCT03443713
Oregon Health and Science UniversityCGM, Exercise, MDI +1
Start: 2018-07-18End: 2019-05-08Updated: 2020-03-18
Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia
TerminatedNCT03748433
Imperial College LondonDiabetes Mellitus, Type 1, Hypoglycemia, Hypoglycemia Unawareness
Start: 2019-01-03End: 2021-09-09Updated: 2024-03-22
Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy
CompletedNCT03761615
Sansum Diabetes Research InstitutePregnancy in Diabetics, Type 1 Diabetes Mellitus
Start: 2018-11-13End: 2021-06-09Updated: 2024-04-12
Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes
CompletedNCT03772600
Universitaire Ziekenhuizen KU LeuvenType 1 Diabetes Mellitus
Start: 2019-01-29End: 2022-11-30Updated: 2022-12-21
Community Glucose Monitoring Project
NCT05351190
Blanchard Valley Health SystemType 2 Diabetes
Start: 2022-05-15End: 2024-12-31Target: 200Updated: 2023-03-09
AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy
CompletedNCT05370612
University of Wisconsin, MadisonPregnancy in Diabetic, Type2Diabetes
Start: 2022-08-08End: 2024-10-06Updated: 2026-03-31
Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)
CompletedNCT05439928
Columbia UniversityDiabetic Ketoacidosis
Start: 2022-06-07End: 2023-03-31Updated: 2025-05-14
Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia
CompletedNCT05746286
DexCom, Inc.Dysglycemia
Start: 2023-02-01End: 2024-06-24Updated: 2025-11-25
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
CompletedNCT05893797
Eli Lilly and CompanyType 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
Start: 2023-10-05End: 2024-09-16Updated: 2025-11-07
DailyDose Smart Snack Study for T1D on MDI
CompletedNCT05967260
Oregon Health and Science UniversityType 1 Diabetes Mellitus With Hypoglycemia
Start: 2023-09-01End: 2024-09-20Updated: 2025-05-31

Related Papers